Phase III Study to Evaluate the Efficacy and Safety of AD-209

Clinical trial NCT06348576 · UNKNOWN

Trial details

NCT number: NCT06348576
Sponsor: Addpharma Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension,Essential

Start date: 2024-05-20
Primary completion: 2025-02-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.